Amplify Seymour Cannabis ETF (CNBS)
- Previous Close
4.7544 - Open
4.6800 - Bid 4.6300 x 1000
- Ask 4.6800 x 800
- Day's Range
4.6350 - 4.7142 - 52 Week Range
3.3800 - 6.4800 - Volume
3,066 - Avg. Volume
47,363 - Net Assets 32.59M
- NAV 4.74
- PE Ratio (TTM) --
- Yield 0.00%
- YTD Daily Total Return 11.34%
- Beta (5Y Monthly) 1.31
- Expense Ratio (net) 0.75%
The fund will invest at least 80% of its net assets in the securities of companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem and in derivatives that have economic characteristics similar to such securities. It is an actively managed ETF that seeks to provide investment exposure to global companies principally engaged in the emerging cannabis and hemp ecosystem across one of three classifications. The fund is non-diversified.
Amplify ETFs
Fund Family
Miscellaneous Sector
Fund Category
32.59M
Net Assets
2019-07-15
Inception Date
Performance Overview: CNBS
Trailing returns as of 6/10/2024. Category is Miscellaneous Sector.
People Also Watch
Holdings: CNBS
Top 6 Holdings (38.78% of Total Assets)
Sector Weightings
Recent News: CNBS
Research Reports: CNBS
Green Thumb Earnings: Few Surprises as Adjusted EBITDA Margin Remains Strong
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates 92 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to U.S. federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RYTHM.
RatingPrice TargetCuraleaf Earnings: Few Surprises but Still Well-Positioned for Many Tailwinds; Shares Undervalued
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
RatingPrice TargetFirst Pillar of Germany's Cannabis Legalization Begins April 1; Legal Sales to Come Later
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 18 states. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.
RatingPrice TargetGreen Thumb's Footprint in Limited License States Makes It Well-Positioned for Legal Market Growth
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates 92 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to U.S. federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RYTHM.
RatingPrice Target